Leukocare AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Leukocare AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10571
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Leukocare AG (Leukocare) is a clinical-stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company’s services include development of spray drying and spray freeze-drying processes, development of individual SPS formulations meeting individual needs of target proteins, and development of customized lyophilization protocols. It also provides coupling of biological compounds to functionalize surfaces, development of vaccine formulation, and establishment of biological readouts. Leukocare offers its services in the areas of biophysics, physiology, biochemistry, pharmacology, immunology, pharmaceutical technology, chemistry and medical engineering, among others. The company provides its services across Germany. Leukocare is headquartered in Munich, Germany.

Leukocare AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Leukocare AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Leukocare AG, Medical Devices Deals, 2012 to YTD 2018 9
Leukocare AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Leukocare AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For Sepsis Dx 11
Leukocare and Xellia Pharma Enter into Partnership Agreement 12
Rentschler Biotech Enters into Agreement with Leukocare 13
Leukocare Enters into Agreement with Technical University of Munich 14
Licensing Agreements 15
PaxVax Enters into Licensing Agreement with Leukocare 15
Leukocare AG – Key Competitors 16
Leukocare AG – Key Employees 17
Leukocare AG – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Other Significant Developments 19
Mar 09, 2018: Rentschler Biopharma and Leukocare demonstrate success of strategic alliance for biopharmaceutical development and formulation 19
Sep 14, 2017: LEUKOCARE Continues to Expand and Invests in Research and Development 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Leukocare AG, Pharmaceuticals & Healthcare, Key Facts 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Leukocare AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Leukocare AG, Deals By Therapy Area, 2012 to YTD 2018 8
Leukocare AG, Medical Devices Deals, 2012 to YTD 2018 9
Leukocare AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For Sepsis Dx 11
Leukocare and Xellia Pharma Enter into Partnership Agreement 12
Rentschler Biotech Enters into Agreement with Leukocare 13
Leukocare Enters into Agreement with Technical University of Munich 14
PaxVax Enters into Licensing Agreement with Leukocare 15
Leukocare AG, Key Competitors 16
Leukocare AG, Key Employees 17

List of Figures
Leukocare AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Leukocare AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Leukocare AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Leukocare AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Humana Inc (HUM):製薬・医療:M&Aディール及び事業提携情報
    Summary Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and …
  • Intrexon Corp (XON)-医療機器分野:企業M&A・提携分析
    Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a provider of therapeutic solutions. The company operates through its divisions such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therap …
  • Celulose Nipo-Brasileira SA:企業の戦略的SWOT分析
    Celulose Nipo-Brasileira SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Crown Bioscience Inc:企業のM&A・事業提携・投資動向
    Crown Bioscience Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Crown Bioscience Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Enterprise Ireland:企業のM&A・事業提携・投資動向
    Enterprise Ireland - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Enterprise Ireland Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • AirStrip Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary AirStrip Technologies Inc (AirStrip) is a healthcare solution provider that offers medical software solutions and services. The company offers mobile interoperability platform interoperability platform that offers access to critical patient data and intelligent insights across the care conti …
  • Calix, Inc. (CALX):企業の財務・戦略的SWOT分析
    Calix, Inc. (CALX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Avillion Berhad:企業の戦略・SWOT・財務分析
    Avillion Berhad - Strategy, SWOT and Corporate Finance Report Summary Avillion Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • N V Nederlandse Gasunie:企業の戦略・SWOT・財務情報
    N V Nederlandse Gasunie - Strategy, SWOT and Corporate Finance Report Summary N V Nederlandse Gasunie - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Direct Energy Marketing Ltd:企業の戦略的SWOT分析
    Direct Energy Marketing Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • American Outdoor Brands Corp:企業の戦略・SWOT・財務分析
    American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report Summary American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CloudFlare Inc (NET):企業の財務・戦略的SWOT分析
    CloudFlare Inc (NET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Streamline Health Solutions Inc (STRM):企業の財務・戦略的SWOT分析
    Summary Streamline Health Solutions Inc (Streamline Health) is a provider of in revenue cycle management. The company offers patient engagement and SaaS-based solutions. Its portfolio of services includes Health Information Management (HIM), patient care, patient engagement, coding and Clinical Docu …
  • Theratechnologies Inc (TH):製薬・医療:M&Aディール及び事業提携情報
    Summary Theratechnologies Inc (Theratechnologies) is a pharmaceutical company that focuses on the discovery and development of drugs for metabolic disorders. The company develops therapeutic peptide products, with an emphasis on growth releasing factor (GRF) peptides. Its lead products include Egrif …
  • American Woodmark Corp (AMWD):企業の財務・戦略的SWOT分析
    American Woodmark Corp (AMWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Hamburg Commercial Bank:企業の戦略・SWOT・財務分析
    Hamburg Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary Hamburg Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Biocodex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Biocodex Inc (Biocodex), a subsidiary of Biocodex, is a pharmaceutical company that manufacturs and distributs probiotic drug products. The company provides products such as Saccharomyces boulardii CNCM I-745 that has a positive effect on the gut's microflora. It also provides Florastor, a y …
  • ICON Plc (ICLR):製薬・医療:M&Aディール及び事業提携情報
    Summary ICON plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides a range of specialized services that span the entire lifecycle of product development. The company …
  • Northern Power Systems Corp (NPS):企業の財務・戦略的SWOT分析
    Summary Northern Power Systems Corp (NPS), formerly Mira III Acquisition Corp is a renewable energy company that offers engineering solutions to energy sector. The company's products comprise wind turbines, power converters, microgrids, power technology products and others. It offers services such a …
  • Federal Electricity & Water Authority:企業の戦略的SWOT分析
    Federal Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆